Gene ontology annotations for HLA-DRA |
|
Experiment description of studies that identified HLA-DRA in exosomes |
1 |
Experiment ID |
110 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSP70|CD81|CD9|HLA-DR|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
"Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P." |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Ascites |
Sample name |
Ascites - Liver cirrhosis |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.04-1.10 g/mL
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting Immunoelctron microscopy |
|
|
2 |
Experiment ID |
37 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD86
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
10878338
|
Organism |
Homo sapiens |
Experiment description |
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. |
Authors |
"Dukers DF, Meij P, Vervoort MB, Vos W, Scheper RJ, Meijer CJ, Bloemena E, Middeldorp JM" |
Journal name |
JIMMU
|
Publication year |
2000 |
Sample |
B cell lymphoblastoid cells |
Sample name |
JY B95-8 |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting |
|
|
3 |
Experiment ID |
11 |
MISEV standards |
✘
|
Biophysical techniques |
✔
HSC70|HSP90|MHCII|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry [MALDI TOF]
|
PubMed ID |
12519789
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. |
Authors |
"Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W" |
Journal name |
JBC
|
Publication year |
2003 |
Sample |
B cells |
Sample name |
RN (HLA-DR15+) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Mass spectrometry [MALDI TOF] Mass spectrometry [QTOF] Western blotting Thin layer chromatography HPLC |
|
|
4 |
Experiment ID |
47 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|CD86
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS
|
PubMed ID |
17641064
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
Journal name |
JIMMU
|
Publication year |
2007 |
Sample |
B cells |
Sample name |
B cells |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
FACS |
|
|
5 |
Experiment ID |
79 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 1 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
6 |
Experiment ID |
80 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis -Sample 2 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
7 |
Experiment ID |
81 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD81|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20458337
|
Organism |
Homo sapiens |
Experiment description |
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis - Sample 3 |
Authors |
"Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W." |
Journal name |
ICB
|
Publication year |
2010 |
Sample |
B cells |
Sample name |
RN (HLA-DR15) |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (MHC Class II) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [FT-ICR] Western blotting |
|
|
8 |
Experiment ID |
42 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD86|TFRC|LAMP2|ITGA2B|CD63|CD9|MHCI|CD81
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
15908444
|
Organism |
Homo sapiens |
Experiment description |
Exosomal-like vesicles are present in human blood plasma. |
Authors |
"Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C" |
Journal name |
INTIMM
|
Publication year |
2005 |
Sample |
Bone marrow cells |
Sample name |
PBMC |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting |
|
|
9 |
Experiment ID |
46 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSC70|CD63|MHCII|CD81|CD86
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Immunoelectron Microscopy Western blotting FACS
|
PubMed ID |
17641064
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
Journal name |
JIMMU
|
Publication year |
2007 |
Sample |
Breast milk |
Sample name |
Breast milk - Colostrum |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.10-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QSTAR] Western blotting Immunoelectron Microscopy FACS |
|
|
10 |
Experiment ID |
48 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSC70|CD63|CD86|MHCII
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Immunoelectron Microscopy Western blotting FACS
|
PubMed ID |
17641064
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
Journal name |
JIMMU
|
Publication year |
2007 |
Sample |
Breast milk |
Sample name |
Breast milk - Mature milk |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.10-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QSTAR] Western blotting Immunoelectron Microscopy FACS |
|
|
11 |
Experiment ID |
46 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSC70|CD63|MHCII|CD81|CD86
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
17641064
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with immune modulatory features are present in human breast milk. |
Authors |
"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S" |
Journal name |
JIMMU
|
Publication year |
2007 |
Sample |
Breast milk |
Sample name |
Breast milk - Colostrum |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.10-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QSTAR] Western blotting Immunoelectron Microscopy FACS |
|
|
12 |
Experiment ID |
49 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
CD63|CD86
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS Immunoelectron Microscopy
|
PubMed ID |
14582906
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. |
Authors |
"Admyre C, Grunewald J, Thyberg J, Gripenback S, Tornling G, Eklund A, Scheynius A, Gabrielsson S" |
Journal name |
ERJ
|
Publication year |
2003 |
Sample |
Bronchoalveolar lavage fluid |
Sample name |
Bronchoalveolar lavage fluid |
Isolation/purification methods |
Differential centrifugation Immunobeads (EpCAM) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
FACS Immunoelectron Microscopy |
|
|
13 |
Experiment ID |
50 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
CD63|CD87
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS Immunoelectron Microscopy
|
PubMed ID |
14582906
|
Organism |
Homo sapiens |
Experiment description |
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. |
Authors |
"Admyre C, Grunewald J, Thyberg J, Gripenback S, Tornling G, Eklund A, Scheynius A, Gabrielsson S" |
Journal name |
ERJ
|
Publication year |
2003 |
Sample |
Dendritic cells |
Sample name |
Monocyte-derived dendritic cells |
Isolation/purification methods |
Differential centrifugation Immunobeads (EpCAM) |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
FACS Immunoelectron Microscopy |
|
|
14 |
Experiment ID |
363 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
15 |
Experiment ID |
364 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
16 |
Experiment ID |
365 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|GAPDH|AQP1|CD151|CD81|CD82|CD9|EPCAM|FLOT1|FLOT2|ICAM1|ITGA2B|LAMP2|RAB35|RAB5A|RAB5B|SDCBP|TFRC|UCHL1
|
Enriched markers |
✔
DCLK1
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
33991177
|
Organism |
Homo sapiens |
Experiment description |
Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells |
Authors |
"Carli ALE, Afshar-Sterle S, Rai A, Fang H, O'Keefe R, Tse J, Ferguson FM, Gray NS, Ernst M, Greening DW, Buchert M." |
Journal name |
Proteomics
|
Publication year |
2021 |
Sample |
Gastric cancer cells |
Sample name |
MKN1 - 100K pellet |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
17 |
Experiment ID |
235 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
18 |
Experiment ID |
4 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
CD63|MHCI|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
11487543
|
Organism |
Homo sapiens |
Experiment description |
Intestinal epithelial cells secrete exosome-like vesicles. |
Authors |
"van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M" |
Journal name |
Not applicable
|
Publication year |
2001 |
Sample |
Intestinal epithelial cells |
Sample name |
HT29-19A T84-DRB1*0401/CIITA |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
19 |
Experiment ID |
56 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSC70|MHCI|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Immunoelectron Microscopy Western blotting
|
PubMed ID |
12147373
|
Organism |
Homo sapiens |
Experiment description |
Malignant effusions and immunogenic tumour-derived exosomes. |
Authors |
"Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L" |
Journal name |
LANCET
|
Publication year |
2002 |
Sample |
Malignant ascites |
Sample name |
Malignant ascites |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.14-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting |
|
|
20 |
Experiment ID |
108 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
HSP70|CD81|CD9|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
"Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P." |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Malignant ascites |
Sample name |
Malignant ascites - Ovarian cancer |
Isolation/purification methods |
"Differential centrifugation Sucrose density gradient Immunobeads (EPCAM, CD24)" |
Flotation density |
1.04-1.15 g/mL
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting Immunoelctron microscopy |
|
|
21 |
Experiment ID |
51 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
14975938
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
Journal name |
AJRCMB
|
Publication year |
2004 |
Sample |
Malignant pleural effusions |
Sample name |
Pleural Fluid - Breast cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
22 |
Experiment ID |
52 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
14975938
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
Journal name |
AJRCMB
|
Publication year |
2004 |
Sample |
Malignant pleural effusions |
Sample name |
Pleural Fluid - Lung cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
23 |
Experiment ID |
53 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP90|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
14975938
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
Journal name |
AJRCMB
|
Publication year |
2004 |
Sample |
Malignant pleural effusions |
Sample name |
Pleural Fluid - Mesothelioma |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF] Western blotting |
|
|
24 |
Experiment ID |
54 |
MISEV standards |
✘
|
Biophysical techniques |
✔
HSP90|MHCII
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
14975938
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes isolated from human malignant pleural effusions. |
Authors |
"Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN" |
Journal name |
AJRCMB
|
Publication year |
2004 |
Sample |
Malignant pleural effusions |
Sample name |
Pleural Fluid - Ovarian adenocarcioma |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting |
|
|
25 |
Experiment ID |
40 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
CD63|CD9|MHCII|TFRC|LAMP2|ITGA2B
|
Enriched markers |
✔
CANX
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
FACS Western blotting
|
PubMed ID |
15908444
|
Organism |
Homo sapiens |
Experiment description |
Exosomal-like vesicles are present in human blood plasma. |
Authors |
"Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C" |
Journal name |
INTIMM
|
Publication year |
2005 |
Sample |
Plasma |
Sample name |
Plasma - Normal |
Isolation/purification methods |
Differential centrifugation Filtration Sucrose density gradient |
Flotation density |
1.15-1.27 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting FACS Immunoelectron Microscopy |
|
|
26 |
Experiment ID |
231 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD63|CD9
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 1 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein Lipids |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
27 |
Experiment ID |
232 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
28 |
Experiment ID |
233 |
MISEV standards |
✘
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25332113
|
Organism |
Homo sapiens |
Experiment description |
Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets |
Authors |
"Pienimaeki-Roemer A, Kuhlmann K, Bottcher A, Konovalova T, Black A, Orso E, Liebisch G, Ahrens M, Eisenacher M, Meyer HE, Schmitz G." |
Journal name |
Transfusion
|
Publication year |
2015 |
Sample |
Platelets |
Sample name |
PL-Exs - Rep 3 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Optiprep density gradient |
Flotation density |
1.12-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
29 |
Experiment ID |
109 |
MISEV standards |
✘
|
Biophysical techniques |
✔
HSP70|CD9|MHCII|HLA-DR|CD24|EpCAM
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Western blotting
|
PubMed ID |
21601258
|
Organism |
Homo sapiens |
Experiment description |
Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage. |
Authors |
"Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P." |
Journal name |
GO
|
Publication year |
2011 |
Sample |
Pleural effusions |
Sample name |
Pleural effusions - Breast cancer |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient Immunobeads (EPCAM) |
Flotation density |
-
|
Molecules identified in the study |
Protein miRNA |
Methods used in the study |
Western blotting |
|
|
30 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
31 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
32 |
Experiment ID |
63 |
MISEV standards |
✘
|
Biophysical techniques |
✔
AQP2
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA" |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
Protein-protein interactions for HLA-DRA |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
DCBLD2 |
131566 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
POMT2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
3 |
ST6GALNAC4 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
4 |
CLCN7 |
1186 |
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
MS4A1 |
931 |
Affinity Capture-MS |
|
Homo sapiens |
Co-localization |
|
Homo sapiens |
|
6 |
PPP2R5D |
5528 |
Affinity Capture-MS |
|
Homo sapiens |
|
7 |
CNTNAP3 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
SCNN1A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
GALNT1 |
2589 |
Affinity Capture-MS |
|
Homo sapiens |
|
10 |
PKM |
5315 |
Affinity Capture-MS |
|
Homo sapiens |
|
11 |
ATP13A2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
12 |
YWHAE |
7531 |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
TMEM206 |
55248 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
14 |
MTG2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
15 |
ECEL1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
16 |
HSP90AB1 |
3326 |
Affinity Capture-MS |
|
Homo sapiens |
|
17 |
TMEM59L |
|
Affinity Capture-MS |
|
Homo sapiens |
|
18 |
PLEKHA2 |
59339 |
Affinity Capture-MS |
|
Homo sapiens |
|
19 |
LNPEP |
4012 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
20 |
SYVN1 |
84447 |
Affinity Capture-MS |
|
Homo sapiens |
|
21 |
GPR110 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
22 |
ST6GALNAC3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
23 |
SERAC1 |
84947 |
Affinity Capture-MS |
|
Homo sapiens |
|
24 |
ITGA7 |
3679 |
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
B3GNT2 |
10678 |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
HLA-DRB3 |
3125 |
Affinity Capture-MS |
|
Homo sapiens |
|
27 |
SEMA6A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
28 |
SLC39A10 |
57181 |
Affinity Capture-MS |
|
Homo sapiens |
|
29 |
TLR3 |
|
Affinity Capture-Western |
|
Homo sapiens |
FRET |
|
Homo sapiens |
|
30 |
ADGRG1 |
9289 |
Affinity Capture-MS |
|
Homo sapiens |
|
31 |
ADAM9 |
8754 |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
BRWD3 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
33 |
FAM8A1 |
51439 |
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
NR2F2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
NETO2 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
36 |
SEL1L |
6400 |
Affinity Capture-MS |
|
Homo sapiens |
|
37 |
PUSL1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
38 |
TMEM106C |
79022 |
Affinity Capture-MS |
|
Homo sapiens |
|
39 |
ABCA2 |
20 |
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
FAM210A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
41 |
EPHA1 |
2041 |
Affinity Capture-MS |
|
Homo sapiens |
|
42 |
SCARB1 |
949 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
43 |
TMEM97 |
27346 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
UGT8 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
45 |
HLA-DQB1 |
3119 |
Affinity Capture-MS |
|
Homo sapiens |
|
46 |
MAN1A1 |
4121 |
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
BTNL2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
KIAA1161 |
57462 |
Affinity Capture-MS |
|
Homo sapiens |
|
49 |
CTAGE5 |
4253 |
Affinity Capture-MS |
|
Homo sapiens |
| | | |